Translational Research Conference
Bone Marrow Failure Disorders - From the cell to the cure of the disease
Chairs: Tim Brümmendorf, Carlo Dufour, Inderjeet Dokal, Régis Peffault de Latour, Marc H.G.P Raaijmakers, Neal Young

Translational Research Conference
Bone Marrow Failure Disorders - From the cell to the cure of the disease
Information
ABOUT THE CONFERENCE:
On behalf of the European School of Haematology and the Severe Aplastic Anaemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT), we are very pleased to invite you to this Translational Research Conference on Bone Marrow Failure Disorders (BMF).
An outstanding faculty of distinguished global experts will present the most recent advances in the field, from the pathophysiology to the diagnosis and therapy of inherited BMF disorders, idiopathic Aplastic Anaemia and Paroxysmal Nocturnal Haemoglobinuria.
The plenary conference programme is designed to place emphasis on leading-edge basic and clinical research. The presentation of unpublished data is encouraged. Ample time is deliberately provided for in-depth scientific discussion and interaction. Registered participants will further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in the field, including during small Meet the Expert sessions and Mentored Posters Walks.
Registered participants are invited to submit their Biology and Clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.
LEARNING OBJECTIVES:
– Improve understanding of the stem cell biology of BMF, from genotoxic stress, inflammaging to failure
– Acquire knowledge of recent advances in Fanconi Anaemia, Ribosome Diseases and Telomeropathy
– Gain insight into novel therapeutics of Paroxysmal Nocturnal Haemoglobinuria and idiopathic Aplastic Anaemia, including knowledge of complement cascade, the current developmental status of various targeted drugs and of novel antibody-based and small molecules based immunotherapeutic approaches, and their promise for future clinical application.
– Acquire an overview of emerging approaches and new challenges such as genetic editing of haemopoietic stem cells, single cell RNA sequencing in haemopoiesis and genetic predisposition for myeloid malignancies.
Programme
Read the final programme!
Corporate partners
With the support of*:

Major E-Conference Partner
*******

Level 1 E-Conference Partners
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.